A Healthy Liver After SVR: Food for Thought

Affiliations

¹ Division of Abdominal Organ Transplantation and Hepatobiliary Surgery, Department of Surgery, University of Southern California, 1510 San Pablo Street, Suite 412, Los Angeles, CA, 90033, USA.
² Division of Gastrointestinal and Liver Diseases, Department of Medicine, University of Southern California, Los Angeles, CA, USA.
³ Division of Abdominal Organ Transplantation and Hepatobiliary Surgery, Department of Surgery, University of Southern California, 1510 San Pablo Street, Suite 412, Los Angeles, CA, 90033, USA. Juliet.emamaullee@med.usc.edu.

Editorial

Brittany Rocque et al. Dig Dis Sci. 2021 Jun.

. 2021 Jun;66(6):1778-1779.

doi: 10.1007/s10620-020-06547-1.

¹ Division of Abdominal Organ Transplantation and Hepatobiliary Surgery, Department of Surgery, University of Southern California, 1510 San Pablo Street, Suite 412, Los Angeles, CA, 90033, USA.
² Division of Gastrointestinal and Liver Diseases, Department of Medicine, University of Southern California, Los Angeles, CA, USA.
³ Division of Abdominal Organ Transplantation and Hepatobiliary Surgery, Department of Surgery, University of Southern California, 1510 San Pablo Street, Suite 412, Los Angeles, CA, 90033, USA. Juliet.emamaullee@med.usc.edu.

No abstract available

Comment on

Lifestyles Associated with Prognosis After Eradication of Hepatitis C Virus: A Prospective Cohort Study in Japan.
Ohfuji S, Matsuura T, Tamori A, Kubo S, Sasaki S, Kondo K, Ito K, Fukushima W. Ohfuji S, et al. Dig Dis Sci. 2021 Jun;66(6):2118-2128. doi: 10.1007/s10620-020-06475-0. Epub 2020 Jul 27. Dig Dis Sci. 2021. PMID: 32720018

1. Geneva, S. W. H. O. Progress report on access to hepatitis C treatment: focus on overcoming barriers in low- and middle-income countries, March 2018. Who (2018) doi:Licence: CC BY-NC-SA 3.0 IGO.
1. Forner A, Reig M & Bruix J Hepatocellular carcinoma. The Lancet (2018) doi:10.1016/S0140-6736(18)30010-2. - DOI - PubMed
1. Ohishi W et al. Risk factors for hepatocellular carcinoma in a Japanese population: A nested case-control study. Cancer Epidemiol. Biomarkers Prev (2008) doi:10.1158/1055-9965.EPI-07-2806. - DOI - PubMed
1. Asahina Y et al. JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2. Hepatol. Res (2016) doi:10.1111/hepr.12645. - DOI - PubMed
1. Nishiguchi S et al. Prevention of hepatocellular carcinoma in patients with chronic active hepatitis C and cirrhosis. Lancet (2001) doi:10.1016/S0140-6736(00)03595-9. - DOI - PubMed